JONBUR Research · Initiation

Cheil Worldwide · 030000 · Business services

Cheil Worldwide: Steady 7% Margins, Net Cash Balance Sheet and a New Buyback Filing

Why this report

Start of coverage: one of the 300 largest companies, written once its financial statements were in.

Cheil Worldwide (KOSPI: 030000) trades at 10.1x earnings and 1.4x book value with a market cap of ₩2.2T, after a 5.3% share price decline over one year. Filed statements show stable operating margins near 7%, a net cash position, and recent filings for a share buyback and cancellation.

Written Oct 13, 2026 · Data as of Oct 12, 2026 · 0 views

This is not financial advice. The report does not recommend buying or selling anything.

Thesis

The data supports a picture of a steady, low-margin business services company. Operating margin has held between 7.3% and 7.5% every year from 2021 to 2025 and was 7.0% on a trailing basis to H1 2026. ROE of 14.3% and very low borrowings add to the stable profile.

The share price is ₩19,310, about 17.1% below the 52-week high of ₩23,300 and 12.9% above the low of ₩17,100. Returns were 2.1% over one month and 2.9% over three months.

What the data does not support is a view on growth. Revenue growth was 4.7% in 2025 and 5.0% in 2024, after a 2.7% decline in 2023. Trailing operating income of ₩315.5B is below the ₩336.9B of 2025. Investor flows, foreign ownership, short balance and news headlines are not available in the data, so market sentiment cannot be assessed.

Business overview

Cheil Worldwide is listed on KOSPI in the business services sector. It was founded on 1973-01-17 and listed on 1998-03-03, with 115,041,225 listed shares. The CEO is listed as 김종현.

Revenue grew from ₩3.33T in 2021 to ₩4.55T in 2025. The largest jump was 27.9% in 2022, followed by a 2.7% decline in 2023, then 5.0% and 4.7% growth. Trailing revenue to H1 2026 is ₩4.48T. The data does not break revenue down by segment or region.

Financial analysis

All figures come from filed financial statements (DART), consolidated where available.

In 2025 revenue was ₩4.55T, operating income ₩336.9B and net income ₩207.5B. Net income was almost unchanged from 2024 (₩207.5B), while operating income rose from ₩320.7B. Operating margin was 7.4% in 2025, 2024 and 2023. ROE was 13.7% in 2025, down from 15.1% in 2024 and 16.6% in 2022.

Trailing figures to H1 2026: revenue ₩4.48T, operating income ₩315.5B (7.0% margin), net income ₩220.0B (4.9% margin), and ROE of 14.3%.

The balance sheet shows cash of ₩574.6B against borrowings of only ₩16.3B. Liabilities to equity are 112.5%. Trailing free cash flow is ₩271.5B.

Valuation

Current multiples are P/E 10.1x, P/B 1.4x and P/S 0.5x. Dividend yield is 5.6%. Enterprise value is ₩1.66T. EV/EBITDA is not available. At the end of 2025 P/E was 11.6x and P/B 1.5x, so the current multiples are slightly lower. Earlier year-end multiples are not available.

Peer comparison is limited. S-1 shows P/E 21.5x and P/B 1.9x, and Doosan Tesna 69.9x and 5.3x. Multiples for Soulbrain Holdings, Lotte Tour Development and Innocean Worldwide are not available. The listed peers are in varied businesses, so the comparison is only a rough guide.

Our simple 5-year discounted cash flow model uses free cash flow of ₩257.9B, growth of 2.2%, a 9.0% discount rate and net cash of ₩558.4B. It gives a fair value range of ₩31,066 (bear), ₩37,708 (base) and ₩46,852 (bull) per share, all above the ₩19,310 price. This is a model output that depends heavily on the assumptions, notably that free cash flow holds up and that the net cash is fully valued. It is not a forecast of the share price.

Catalysts

  • On 2026-09-30 the company filed share buyback and share cancellation decisions, which could reduce the share count if carried out.
  • A trading halt and a fair disclosure filing were also dated 2026-09-30, alongside the buyback decision.
  • Changes in the largest shareholder's holdings were filed on 2026-07-31, 2026-08-28 and 2026-10-02.
  • The half-year report for June 2026 was filed on 2026-08-14, and IR events were held on 2026-07-30 and 2026-08-21.
  • The 5.6% dividend yield is a visible feature of the data, though the dividend history is not provided.

Risks

  • Trailing operating income of ₩315.5B is below the ₩336.9B reported for 2025, and the trailing operating margin is 7.0% against 7.4%.
  • Revenue growth has been modest at 4.7% in 2025 after a 2.7% decline in 2023, so the business has shown limited expansion recently.
  • ROE has drifted from 16.6% in 2022 to 14.3% on a trailing basis.
  • Investor flows, foreign ownership and short interest are not available, so shifts in market positioning cannot be assessed.
  • Model fair values rest on assumptions about free cash flow, growth and discount rate, and small changes could move the range materially.

Closing view

The data describes a company with stable margins, little debt, a sizeable cash balance and a 5.6% dividend yield, trading at 10.1x earnings. The model range sits well above the current price, but it is sensitive to assumptions, and trailing profit is slightly below the 2025 level. The new buyback and cancellation filings are a notable recent event. Missing data on flows, ownership, short interest, news and peer multiples limits the picture, so this report is a summary of filed numbers rather than a recommendation.

Model estimate of fair value

Bear
₩31,066
+68%
Base
₩37,708
+104%
Bull
₩46,852
+153%

Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal.

A simple 5-year discounted cash flow from filed statements (H1 2026): revenue growth 2.2% fading to 2%, discount rate 9%. Per share, not a price target. See and change the assumptions

Filings and data used

Report history

  1. Oct 13, 2026InitiationStart of coverage (300 largest)Cheil Worldwide: Steady 7% Margins, Net Cash Balance Sheet and a New Buyback Filing

Built only from jonbur's own data: prices and investor flows, filed financial statements and filings, and news headlines. Disclosed (filed) data is labelled as such. Written by AI and may contain mistakes.

This is not financial advice. The report does not recommend buying or selling anything.

Source: KRX statistical information